U.S. China Research Gets Caught In Cross Fire Of Student Uprising

As the echoes of the tanks on Beijing’s Tiananmen Square begin to fade, scientists from the United. States whose research requires access to Chinese sites--and their Chinese counterparts working or studying in the U.S.—are wondering whether they should permanently write off their projects as casualties of the violence. Universities, private companies, national agencies, and individual scientists have spent years overcoming xenophobia, language barriers, and other obstacles to ]

Written byBarbara Spector
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

As the echoes of the tanks on Beijing’s Tiananmen Square begin to fade, scientists from the United. States whose research requires access to Chinese sites--and their Chinese counterparts working or studying in the U.S.—are wondering whether they should permanently write off their projects as casualties of the violence.

Universities, private companies, national agencies, and individual scientists have spent years overcoming xenophobia, language barriers, and other obstacles to ] But one thing is clear: For now at least, they must put their plans for joint research on hold while the governments of the U.S. and the People’s Republic of China (PRC) plan their next steps in the wake of the squelched Chinese student uprising and subsequent executions.

While the crackdown on Chinese citizens threatens the future of many corporate research collaborations, scientists at most U.S. firms involved are proceeding as best they can. At New York-based Grumman Corp., for instance, although ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies